Mulder, A B <br/><br/>
Response to "The efficacy of simvastatin is not influenced by CYP2D6 polymorphism" by Geisel et al.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  May 2003 
 - 475 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/s0009-9236(03)00054-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Anticholesteremic Agents--pharmacokinetics<br/>Cytochrome P-450 CYP2D6--genetics<br/>Humans<br/>Hypercholesterolemia--drug therapy<br/>Mutation--genetics<br/>Polymorphism, Genetic--genetics<br/>Simvastatin--pharmacokinetics